Literature DB >> 9146787

The role of antisecretory drugs in the treatment of Helicobacter pylori infection.

W L Peterson1.   

Abstract

The efficacy of antibiotics against Helicobacter pylori is enhanced by the co-administration of antisecretory drugs. While proton pump inhibitors appear to have some direct effect on H. pylori and extreme hypochlorhydria has a deleterious effect on the organism, the most likely mechanism by which antisecretory drugs as a class provide this effect is by improving the efficacy of the antibiotics themselves. Although proton pump inhibitors are the most widely used antisecretory agents, H2 receptor antagonists also enhance antibiotic effects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9146787     DOI: 10.1046/j.1365-2036.11.s1.4.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  9 in total

Review 1.  Potent gastric acid inhibition in Helicobacter pylori eradication.

Authors:  Javier P Gisbert
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Association of helicobacter pylori dupA with the failure of primary eradication.

Authors:  Seiji Shiota; Lam Tung Nguyen; Kazunari Murakami; Akiko Kuroda; Kazuhiro Mizukami; Tadayoshi Okimoto; Masaaki Kodama; Toshio Fujioka; Yoshio Yamaoka
Journal:  J Clin Gastroenterol       Date:  2012-04       Impact factor: 3.062

3.  Effect of acid secretion blockade by omeprazole on the relative bioavailability of orally administered furazolidone in healthy volunteers.

Authors:  S A Calafatti; R A Ortiz; M Deguer; M Martinez; J Pedrazzoli
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

4.  Evaluation of the Anti-Ulcer Activity of Hydromethanolic Crude Extract and Solvent Fractions of the Root of Rumex nepalensis in Rats.

Authors:  Woretaw Sisay Zewdu; Tezera Jemere Aragaw
Journal:  J Exp Pharmacol       Date:  2020-09-14

Review 5.  Virulence factor genotypes of Helicobacter pylori affect cure rates of eradication therapy.

Authors:  Mitsushige Sugimoto; Yoshio Yamaoka
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-02-14       Impact factor: 4.291

Review 6.  The use of proton pump inhibitors in children: a comprehensive review.

Authors:  Troy E Gibbons; Benjamin D Gold
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

7.  Efficacy of esomeprazole in treating acid-related diseases in Japanese populations.

Authors:  Mitsushige Sugimoto; Takahisa Furuta
Journal:  Clin Exp Gastroenterol       Date:  2012-05-14

8.  A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori.

Authors:  P Patrick Basu; Krishna Rayapudi; Tommy Pacana; Niraj James Shah; Nithya Krishnaswamy; Molly Flynn
Journal:  Am J Gastroenterol       Date:  2011-10-11       Impact factor: 10.864

9.  Randomized Trial Comparing Esomeprazole and Rabeprazole in First-line Eradication Therapy for Helicobacter pylori Infection based on the Serum Levels of Pepsinogens.

Authors:  Tadashi Shimoyama; Daisuke Chinda; Yoshihiko Sawada; Kazuo Komai; Hironobu Chiba; Yoshiharu Saito; Yoshio Sasaki; Masashi Matsuzaka; Shinsaku Fukuda
Journal:  Intern Med       Date:  2017-07-01       Impact factor: 1.271

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.